Golconda Res Ltd (GOLCF) 0.0010 $GOLCF Golconda

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Golconda Res Ltd (GOLCF) 0.0010 $GOLCF

Golconda Resources Ltd. Dissolution
Marketwired - Fri Apr 29, 1:06PM CDT
Golconda Resources Ltd. (NEX: GA.H) (the "Corporation" or "Golconda" announces that at the special meeting (the "Meeting" of the shareholders of the Corporation (the "Shareholders" held on April 29, 2016, more than 98% of the common shares of the Corporation represented at the Meeting voted in favour of a special resolution to voluntarily dissolve the Corporation (the "Dissolution". The Corporation has no assets or liabilities and the board of directors has resolved to proceed with the Dissolution.

IIROC Trade Halt - Golconda Resources Ltd.
Newsfile Corp - Fri Apr 29, 11:35AM CDT
The following issues have been halted by IIROC:

IIROC Trading Halt - GA.H
CNW Group - Fri Apr 29, 11:33AM CDT
The following issues have been halted by IIROC:

Golconda Resources Ltd. Strategic Alternatives Process
Marketwired - Fri Apr 01, 6:10PM CDT
Golconda Resources Ltd. (NEX: GA.H) (the "Corporation" or "Golconda" announces that its Board of Directors (the "Board" has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Corporation and its shareholders to dissolve the Corporation (the "Dissolution". The Corporation does not currently have any ongoing business operations and currently anticipates that it will have no assets to liquidate or cash to distribute to its shareholders in connection with the Dissolution. Notwithstanding the foregoing, until such time as shareholder approval for the Dissolution is received, the Corporation will continue to evaluate other opportunities that have the potential of providing a return to its shareholders.

Golconda Resources Ltd. Transfers to NEX
Marketwired - Wed Jul 22, 9:59AM CDT
Golconda Resources Ltd. (the "Corporation" (NEX: GA.H) announces that it has been advised by the TSX Venture Exchange that its tier classification was changed from Tier 2 to NEX effective Wednesday, July 22, 2015.

Golconda Resources Ltd.: Corporate Update
Marketwired - Wed Apr 01, 3:43PM CDT
Golconda Resources Ltd. (the "Corporation" or "Golconda" (TSX VENTURE: GA) announces that Robert Gillies has resigned as Chief Financial Officer of the Corporation. The Board of Directors and Management thank Bob for his years of dedicated and professional service and wish him well in his future endeavors.

Golconda Resources Ltd. Announces Meeting Results
Marketwired - Fri Jan 23, 5:22PM CST
Golconda Resources Ltd. (TSX VENTURE: GA) (the "Corporation" or "Golconda" announces that at the annual general and special meeting held in Calgary, Alberta on January 23, 2015 (the "Meeting" holders of common shares of the Corporation: (i) re-elected Howard G. Coopersmith, David E. Mullen, Gerald N. Gilewicz, Thomas E. Callicrate and Robert J. Hunt to the board of directors; (ii) re-appointed KPMG LLP as the auditors of the Corporation; (iii) ratified the stock option plan; (iv) approved the consolidation of the common shares of the Corporation on the basis of one (1) post-consolidation share for up to every 10 pre-consolidation shares; and (v) approved the sale of the Corporation's interest in the joint venture agreement with respect to oil and gas exploration and development on approximately 1,600 acres of lands in the Cold Lake area in northeast Alberta (the "Asset Sale Transaction". The Asset Sale Transaction is expected to close in the next two weeks and is subject to customary closing conditions, including the approval of the TSX Venture Exchange.

Golconda Announces Disposition
Marketwired - Mon Jan 05, 3:31PM CST
Golconda Resources Ltd. (TSX VENTURE: GA) (the "Corporation" or "Golconda" announces that its wholly-owned subsidiary, Golconda Gold, Inc. has disposed of an aggregate of 17 "RV" unpatented lode mining claims and associated data situated in Nye County, Nevada (the "Assets" to Mountain Gold Claims, LLC, Series 27 ("Mountain Gold" (the "Disposition". As consideration for the Disposition, Mountain Gold granted Golconda Gold a royalty equal to 1% of the Net Smelter Return received from the sale of minerals produced from the Assets.

Golconda Resources Ltd. Announces Additional Cold Lake Joint Venture
Marketwired - Tue Dec 23, 3:39PM CST
Golconda Resources Ltd. (the "Corporation" or "Golconda" (TSX VENTURE: GA) announces that it has entered into a joint venture agreement (the "JVA" with Kasten Energy Inc., a Calgary based private oil and gas company ("Kasten", and Tri Rez Legoff Energy Ltd. ("TRL", the Cold Lake First Nation ("CLFN" oil and gas company, with respect to the conduct of oil and gas exploration and development of approximately one section of CLFN lands. Pursuant to the JVA, TRE has agreed with Golconda and Kasten to acquire from Indian Oil and Gas (IOGC) a lease covering the lands. The JVA provides that Golconda and Kasten shall spud or re-enter the earning well prior to August 31, 2015 in order to earn the section of the lands.

IIROC Trading Resumption - GA
CNW Group - Fri Dec 12, 10:21AM CST
Trading resumes in:

IIROC Trade Resumption - Golconda Resources Ltd.
Newsfile Corp - Fri Dec 12, 10:15AM CST
Trading resumes in:

Golconda Resources Ltd. Agrees to Sell Cold Lake Joint Venture Interest
Marketwired - Fri Dec 12, 10:05AM CST
Golconda Resources Ltd. (TSX VENTURE: GA) (the "Corporation" or "Golconda" announces that it has entered into a definitive purchase and sale agreement (the "PSA" with Kasten Energy Inc., a Calgary-based private oil and gas company ("Kasten", that provides for the sale of the Corporation's interest in the joint venture agreement among the Corporation, Kasten and Tri-Rez Ebay Energy Ltd. (the "JVA" with respect to oil and gas exploration and development on approximately 1,600 acres of lands in the Cold Lake area in northeast Alberta (the "Asset Sale Transaction". Completion of the Asset Sale Transaction will result in the sale of substantially all of the assets of the Corporation and requires approval by not less than 66 2/3% of the votes cast by the Corporation's shareholders, voting in person or by proxy, at the Corporation's upcoming annual and special meeting of shareholders which is currently expected to be held on January 23, 2015 (the "Meeting".

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading